2019
DOI: 10.1016/j.psychres.2018.12.015
|View full text |Cite
|
Sign up to set email alerts
|

BDNF mediates the protective effects of scopolamine in reserpine-induced depression-like behaviors via up-regulation of 5-HTT and TPH1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
23
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(24 citation statements)
references
References 43 publications
1
23
0
Order By: Relevance
“…RNA‐sequencing validation by qRT‐PCR showed that the upregulated and downregulated genes were consistent between independent experiments (Figure ). These DEGs were mainly involved in inflammation, neurodevelopment, synaptic plasticity, synaptic transmission, neurotropin binding, neurotrophic binding, signal transduction and cellular communication, which are associated with depressive episodes and therapy . These results suggested that the antidepressant activities of LBRD standard decoction might be achieved by targeting multiple targets in the medial prefrontal cortex.…”
Section: Discussionmentioning
confidence: 85%
“…RNA‐sequencing validation by qRT‐PCR showed that the upregulated and downregulated genes were consistent between independent experiments (Figure ). These DEGs were mainly involved in inflammation, neurodevelopment, synaptic plasticity, synaptic transmission, neurotropin binding, neurotrophic binding, signal transduction and cellular communication, which are associated with depressive episodes and therapy . These results suggested that the antidepressant activities of LBRD standard decoction might be achieved by targeting multiple targets in the medial prefrontal cortex.…”
Section: Discussionmentioning
confidence: 85%
“…Several randomized double-blind studies have been performed and demonstrated contrasting outcomes. Some studies found scopolamine to have a rapid and prominent effect [44] while others found no benefit from scopolamine over placebo [45] for the treatment of these conditions. The contrasting findings indicate that more extensive studies are needed to verify the use of scopolamine for treatment of CNS diseases.…”
Section: Pharmacology Of Tas and Their Role As Drug Lead Substancesmentioning
confidence: 99%
“…However, the underlying mechanism of DDs following HCC remains unknown. Reserpine is used to establish mouse depression models [25]. Reserpine is not lethal, and a chronic rather than an acute dose of reserpine was used in this study to induce DD in mice.…”
Section: Discussionmentioning
confidence: 99%